Primary Pulmonary Malignant Fibrous Histiocytoma

Simple item page
dc.contributor.authorCosgun, Tugba
dc.contributor.authorTezel, Yelda
dc.contributor.authorAkyil, Mustafa
dc.contributor.authorKolbas, Ilker
dc.contributor.authorSen, Aycim
dc.contributor.authorTezel, Cagatay
dc.date.accessioned2023-02-21T12:34:49Z
dc.date.available2023-02-21T12:34:49Z
dc.date.issued2017-01-01
dc.description.abstractMalignant fibrous histiocytoma (MFH) cases are classified within the group of nonclassified sarcomas. The etiopathogenesis is unclear
dc.description.abstracthowever, MFH commonly develops in scar tissue and in areas exposed to radiation. MFH is the most common soft tissue sarcoma in adults and may be borne in the lungs, chest wall, mediastinum, or other tissues. Primary MFH of the lung constitutes less than 0.2\% of all pulmonary neoplasms
dc.description.abstractthus, an optimal treatment strategy has not yet been elucidated. We aimed to report a case of MFH of the lung with subsequent treatment administration.
dc.description.issue2
dc.description.issueAPR
dc.description.pages54-56
dc.description.volume18
dc.identifier.doi10.5152/TurkThoracJ.2017.16039
dc.identifier.urihttps://hdl.handle.net/11443/1819
dc.identifier.urihttp://dx.doi.org/10.5152/TurkThoracJ.2017.16039
dc.identifier.wosWOS:000399794400007
dc.publisherAVES
dc.relation.ispartofTURKISH THORACIC JOURNAL
dc.subjectMalignant fibrous histiocytoma
dc.subjectpulmonary neoplasm
dc.subjectlung
dc.titlePrimary Pulmonary Malignant Fibrous Histiocytoma
dc.typeArticle

Files

Collections

WOS